|
|
|
|
Vol. 53, Issue 1, 135-140, January 1998
Respiratory Sciences Center (T.D.L., J.W.B., D.G.A., J.L.H., M.H.)
and the Departments of
Pharmacology (T.D.L., J.W.B., M.H.) and
Medicine
(J.W.B.), College of Medicine, University of Arizona Health Sciences
Center, Tucson, Arizona 85724
Platelet-activating factor (PAF) has been implicated in the
pathogenesis of allergic and inflammatory events in the airway. In the
present study, we sought to determine if PAF receptors are present on
human bronchial epithelial cells and whether PAF binding to these
receptors leads to activation of activator protein-1 (AP-1)-mediated
transcription. Radioligand binding studies demonstrated specific
binding sites for the PAF antagonist [3H]WEB 2086 (3-[4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-[1,2,4]triazolo[4,3- a][1,4]diazepine-2-yl]-1-(4-morpholinyl)-1-propanone)
on primary bronchial epithelial cells with an equilibrium dissociation
constant (Kd) = 9.8 nM and maximal density of binding sites
(Bmax) = 42.4 fmol/mg of protein. The
expression of PAF receptors in these cells was further confirmed by
reverse transcriptase-polymerase chain reaction, which revealed
amplification products derived from PAF receptor mRNA corresponding to
transcripts 1 and 2. In the bronchial epithelial cell line BEAS-2B
transfected with an expression plasmid for the human PAF receptor, PAF
stimulation increased AP-1 DNA binding activity as determined by
electrophoretic mobility shift assays. The Fos and Jun family proteins
were identified as components of the DNA-protein complexes by
anti-peptide antibodies in gel supershift assays. Additionally, PAF
significantly induced AP-1 mediated transcription which was dependent
on the expression of PAF receptors. The PAF antagonist WEB 2086 blocked
the PAF effect but not that induced by
12-O-tetradecanoyl phorbol-13-acetate, indicating the
specificity of the PAF response. These results indicate that activation
of airway epithelial cells through stimulation of PAF receptors
includes up-regulation of the nuclear transcription factor AP-1 and
AP-1 transcriptional activity.
This article has been cited by other articles:
![]() |
P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rahman and W. MacNee Role of transcription factors in inflammatory lung diseases Thorax, July 1, 1998; 53(7): 601 - 612. [Full Text] |
||||